Fortress Biotech Inc. (FBIOP)
NASDAQ: FBIOP
· Real-Time Price · USD
7.79
0.64 (8.95%)
At close: Aug 15, 2025, 12:49 PM
7.88
1.21%
After-hours: Aug 15, 2025, 04:00 PM EDT
Fortress Biotech Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -24.69M | -26.32M | -12.87M | -10.95M | -39.02M | -9.28M | -10.72M | -59.3M | -55.15M | -57.45M | -53.06M | -53.93M | -49.48M | -68.51M | -45.86M | -24.39M | -26.07M |
Depreciation & Amortization | 1.68M | -1.24M | -2.91M | 1.19M | 1.19M | 1.71M | 2.75M | 1.18M | 1.91M | 2.59M | 2.34M | 2.22M | 2.2M | 1.68M | 1.74M | 1.77M | 1.6M |
Stock-Based Compensation | n/a | 16.19M | n/a | 5M | 4.86M | 3.7M | 4.38M | 4.22M | 4.73M | 5.51M | 6.84M | 5.08M | 5.56M | 7.04M | 4.33M | 4.35M | 3.77M |
Other Working Capital | n/a | -4.57M | 686K | 2.13M | -1.89M | -4.43M | -784K | 549K | 25K | -4.05M | -1.39M | -378K | 384K | -3.33M | -2.33M | -1.28M | 7.69M |
Other Non-Cash Items | 628K | 4.19M | 585K | -13.89M | 1.92M | 7.93M | 76K | 2.82M | -865K | 490K | 874K | 1.01M | 516K | 4.5M | 7.2M | 12.08M | 656K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -20.85M | -5M | 10.05M | n/a | n/a | n/a | n/a | n/a | 378K | -12.13M | -21.21M | -5.84M |
Change in Working Capital | n/a | -5.73M | -4.87M | -3.19M | 5.67M | -18.15M | -8.26M | 7.75M | 6.15M | 1.01M | -267K | 4.2M | -5.66M | 16.22M | 23.03M | -7.06M | 4.19M |
Operating Cash Flow | -19.56M | -12.91M | -20.06M | -21.84M | -25.39M | -34.94M | -16.78M | -33.29M | -43.22M | -47.84M | -43.27M | -41.42M | -46.86M | -38.7M | -21.7M | -34.46M | -21.69M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | -63K | -1M | -34K | n/a | -391K | -1.02M | -307K | -1.34M | -3.51M | -7.54M | -4.84M | -458K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5M | -5M | 20M | -20M | 20M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 1.17M | -15M | n/a | n/a | n/a | -35K | 5M | -7M | n/a | -20M | 20.13M | -20M | -20M | 55.31M | -7.08M | -3.15M | n/a |
Investing Cash Flow | 1.17M | -15M | n/a | n/a | n/a | -63K | 5M | -2.04M | -5M | -391K | -893K | -307K | -21.34M | 53.35M | -7.54M | -4.84M | -458K |
Debt Repayment | -625K | 5M | -17.33M | 5M | n/a | 14.62M | -10M | -43.47M | 52K | 2.95M | 5M | -17K | 41.32M | -10.45M | -2.5M | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -371K | n/a | n/a | n/a | n/a |
Dividend Paid | -166K | -166K | -176K | -2.18M | -2.18M | -2.19M | -2.19M | -2.19M | -2.19M | -2.19M | -2.2M | -2.2M | -2.19M | -2.19M | -2.19M | -2.01M | -2.19M |
Other Financial Acitivies | 51.3M | -217K | -160K | -4.55M | 4.76M | 479K | -889K | 15.28M | n/a | -1.79M | -627K | n/a | 12.54M | 5.26M | -170K | -1.09M | -3.2M |
Financial Cash Flow | 52.14M | 25.81M | 2.71M | 14.27M | 27.86M | 43.62M | -2.69M | -30.38M | 22.19M | 18.62M | 3.75M | 2.99M | 49.96M | 38.94M | 6.97M | 24.39M | 78.69M |
Net Cash Flow | 33.74M | -2.1M | -17.35M | -7.57M | 2.47M | 6.18M | -14.46M | -65.71M | -26.03M | -29.62M | -40.42M | -38.74M | -18.23M | 53.6M | -22.27M | -14.9M | 56.55M |
Free Cash Flow | -19.56M | -27.91M | -20.06M | -21.84M | -25.39M | -35M | -17.78M | -33.33M | -43.22M | -48.23M | -44.29M | -41.73M | -48.2M | -42.2M | -29.24M | -39.3M | -22.15M |